Cookies


ESHRE ® uses cookies to improve your browsing experience on its website, as defined in the Cookie Policy (as updated on 18/03/2024). Strictly necessary cookies are necessary for the proper functioning of the Website – therefore, you cannot refuse them. Other, non-strictly necessary cookies are only placed if you consent to their use. Read more about it in our Cookie Policy. Do you agree with our use of non-strictly necessary cookies?
Manage my cookie preferences

London is Calling! Register here for ESHRE 2026!

New ESHRE Good Practice Recommendations paper ready for stakeholder feedback

15 May 2026

Expanded Carrier Screening (ECS) for reproductive purposes is a genetic testing strategy intended to identify individuals or couples who carry pathogenic/likely pathogenic variants in genes associated with autosomal recessive (AR) or X-linked recessive (XLR) conditions.
The purpose of this paper is to establish good practice recommendations for the implementation of ECS in MAR centres, to promote standardised, ethical, and effective use that can support informed reproductive decision-making.
The Good Practice Recommendations paper is open for stakeholder review between 15 May and 12 June 2026.

Endocrine disrupting chemicals (EDCs): A hidden threat to fertility

24 April 2026

On World Hormone Day, ESHRE is publishing an infographic on the harmful effects of endocrine disrupting chemicals (EDCs) on fertility, developed in collaboration with Fertility Europe and the European Society of Endocrinology.

Ultra-processed foods are linked to reduced fertility and embryonic development

24 March 2026

Human Reproduction Press Release
Eating large amounts of ultra-processed food (UPF) is linked not only to reduced fertility in men, but also to slower growth in early embryos, and smaller yolk sacs, which are essential for early embryonic development, according to new research.

Increased risk of premature births is linked to use of weight loss drugs during early pregnancy, but only when they are used to treat diabetes

18 March 2026

Human Reproduction Press Release
Weight loss drugs have been linked to an increased risk of premature births among women who took them inadvertently just before or during early pregnancy to treat pre-existing diabetes.